Showing results (121-130 of 183) with videos related to
Sort By:
Pageof 19
Cancer Research|June 18, 2003
Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapyMarka Crittenden, Michael Gough, John Chester, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
Exploiting viral infection/vaccination to focus high-affinity T cell populations into tumors using oncolytic viro-immunotherapyAlexa Veliz Rios, Muriel Metko, Jason Tonne, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic VirusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.Nature Biotechnology|August 10, 2004
A simple method to cure established tumors by inflammatory killing of normal cellsGregory A Daniels, Luis Sanchez-Perez, Rosa Maria Diaz, et al.The Journal of Clinical Investigation|September 30, 2025
ER stress upregulates S100A11 in steatohepatitis models via epigenetic modifications within the lipotoxicity-influenced enhancerP Vineeth Daniel, Hanna L Erickson, Daheui Choi, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|April 14, 2018
Practice Change From Intermittent Medication Boluses to Bolusing From a Continuous Infusion in Pediatric Critical Care: A Quality Improvement ProjectJessica L Hochstetler, A Jill Thompson, Natalie M Ball, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapseNicolas Boisgerault, Timothy Kottke, Jose Pulido, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirusJian Qiao, Hongxun Wang, Timothy Kottke, et al.Nature Medicine|June 21, 2011
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsTimothy Kottke, Fiona Errington, Jose Pulido, et al.Pageof 19